These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1613 related articles for article (PubMed ID: 33689759)

  • 21. Gait variability is affected more by peripheral artery disease than by vascular occlusion.
    Rahman H; Pipinos II; Johanning JM; Myers SA
    PLoS One; 2021; 16(3):e0241727. PubMed ID: 33788839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral Artery Disease and Abdominal Aortic Aneurysm: The Forgotten Diseases in COVID-19 Pandemic. Results from an Observational Study on Real-World Management.
    Natale F; Capasso R; Casalino A; Crescenzi C; Sangiuolo P; Golino P; Loffredo FS; Cimmino G
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34209552
    [No Abstract]   [Full Text] [Related]  

  • 23. Adapting vascular care amidst a pandemic: Considering COVID-19 and looking forward.
    Bunte MC; Monteleone PP
    Vasc Med; 2021 Dec; 26(6):624-625. PubMed ID: 34380346
    [No Abstract]   [Full Text] [Related]  

  • 24. SARS-COV-2 Pandemic for Patients with Chronic Obstructive Peripheral Arterial Disease: Impact of Interruption to Access According to Gender in a Single Center Experience.
    Traina L; Tsolaki E; Rocca T; Mucignat M; Gabellini T; Lamberti N; Manfredini F; Gasbarro V
    Ann Vasc Surg; 2023 Feb; 89():129-134. PubMed ID: 36471513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Open revascularization procedures are more likely to influence smoking reduction than percutaneous procedures.
    Rajaee S; Cherkassky L; Marcaccio EJ; Carney WI; Chong TT; Garcia-Toca M; Slaiby JM
    Ann Vasc Surg; 2014 May; 28(4):990-8. PubMed ID: 24556178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the Impact of the COVID-19 Pandemic in Spain: Large-Scale, Online, Self-Reported Population Survey.
    Oliver N; Barber X; Roomp K; Roomp K
    J Med Internet Res; 2020 Sep; 22(9):e21319. PubMed ID: 32870159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repercussion of COVID-19 Pandemic on Brazilians' Quality of Life: A Nationwide Cross-Sectional Study.
    Teotônio I; Hecht M; Castro LC; Gandolfi L; Pratesi R; Nakano EY; Puppin Zandonadi R; Pratesi CB
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33218087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the COVID-19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study.
    Sacre JW; Holmes-Truscott E; Salim A; Anstey KJ; Drummond GR; Huxley RR; Magliano DJ; van Wijngaarden P; Zimmet PZ; Speight J; Shaw JE
    Diabet Med; 2021 Sep; 38(9):e14611. PubMed ID: 34053106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudden Changes and Their Associations with Quality of Life during COVID-19 Lockdown: A Cross-Sectional Study in the French-Speaking Part of Switzerland.
    Duay M; Morgiève M; Niculita-Hirzel H
    Int J Environ Res Public Health; 2021 May; 18(9):. PubMed ID: 34064382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative Number of Treatment Interventions Predicts Health-Related Quality of Life in Patients with Critical Limb Ischemia.
    Corriere MA; Goldman MP; Barnard R; Saldana S; Stafford JM; Easterling D; Ip EH; Burke GL
    Ann Vasc Surg; 2017 Oct; 44():41-47. PubMed ID: 28479452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychometric properties of the disease-specific health-related quality of life instrument VascuQoL in a Swedish setting.
    Nordanstig J; Karlsson J; Pettersson M; Wann-Hansson C
    Health Qual Life Outcomes; 2012 Apr; 10():45. PubMed ID: 22545952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of exercise ankle-brachial index, pain-free walking distance and maximum walking distance with the Peripheral Artery Questionnaire: Finding from the PORTRAIT PAD Registry.
    Hammad TA; Smolderen KG; Spertus JA; Jones PG; Shishehbor MH
    Vasc Med; 2019 Feb; 24(1):32-40. PubMed ID: 29992849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery Disease: The MOSAIC Randomized Clinical Trial.
    Bearne LM; Volkmer B; Peacock J; Sekhon M; Fisher G; Galea Holmes MN; Douiri A; Amirova A; Farran D; Quirke-McFarlane S; Modarai B; Sackley C; Weinman J; Bieles J;
    JAMA; 2022 Apr; 327(14):1344-1355. PubMed ID: 35412564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical validity of a disease-specific health status questionnaire: the peripheral artery questionnaire.
    Hoeks SE; Smolderen KG; Scholte Op Reimer WJ; Verhagen HJ; Spertus JA; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):371-7. PubMed ID: 19028064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.
    Sen I; Agarwal S; Tharyan P; Forster R
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009366. PubMed ID: 29658630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 81.